GSK, Sanofi en­list in a big ge­nomics project aim­ing to map genes of half a mil­lion Finns

Sev­er­al Eu­ro­pean coun­tries, in­clud­ing Ice­land and the Nether­lands, have an­a­lyzed ge­nom­ic in­for­ma­tion to study their pop­u­lace. Two years ago, Fin­land be­gan its very own large scale pub­lic-pri­vate ge­nomics project – aimed at map­ping the genomes of 500,000 cit­i­zens (or rough­ly 9% of the coun­try’s pop­u­la­tion) to de­code the ori­gins of dis­ease for pre­ven­tion, di­ag­no­sis and treat­ment. GSK and Sanofi have now joined the ef­fort, bring­ing the to­tal num­ber of phar­ma­ceu­ti­cal part­ners to nine.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER